Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 1,3 Butanediol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104651243A reveals a biocatalytic route for (R)-1,3-butanediol. Offers high purity and yield for antibiotic synthesis, ensuring reliable supply chain solutions.
Patent CN112538095B reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity (R)-1,3-butanediol, offering significant cost reduction and scalability.
Patent CN109749968A details Bacillus velezensis strain for efficient (R)-1,3-butanediol synthesis. Delivers high purity, mild conditions, and supply chain stability for pharmaceutical manufacturing.
Patent CN104651243B details high-yield biocatalytic synthesis of (R)-1,3-butanediol. Offers superior purity and cost-effective supply chain solutions for antibiotic manufacturing.
Patent CN109749968B reveals a novel Bacillus velezensis strain for synthesizing chiral intermediates. This breakthrough offers significant cost reduction in API manufacturing and superior supply chain reliability.